Keywords: trandolapril, shows, significant, benefit, post-mi, patients, treatment

Trandolapril Shows Significant Benefit In Post-MI Patients

Article | 19 September 1994

Treatment with the angiotensin-converting enzyme inhibitor trandolapril (Roussel Uclaf's Odrik) caused a decrease in overall mortality of 22% in survivors of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Mavik

trandolapril

Covera-HS

Verapamil

Verelan PM

Go to drug listing